We are live on ! Find out more
BPTH

Bio-Path Holdings Inc

Delisted

BPTH was delisted on the 18th of February, 2025.

38 hedge funds and large institutions have $42.3M invested in Bio-Path Holdings Inc in 2014 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

120% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 5

51% more capital invested

Capital invested by funds: $28.1M → $42.3M (+$14.2M)

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

0% more funds holding

Funds holding: 3838 (0)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
38
Holders Change
Holders Change %
0%
% of All Funds
1.01%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
6
Increased
11
Reduced
5
Closed
5
Calls
Puts
Net Calls
Net Calls Change

BPTH Hedge Fund Activity: Q4 2014 in Review

38 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q4 2014, worth a combined $42.3M — up 51% from $28.1M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new BPTH positions and 5 closed out — a net gain of 1 holder — while 11 added to existing stakes and 5 trimmed.

The largest buyer was Creative Planning, adding an estimated $3.96M. The largest seller was Bluefin Capital Management, exiting entirely with an estimated $233K sold.

  • 38 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q4 2014, unchanged from Q3 2014.
  • Funds reported $42.3M of Bio-Path Holdings Inc stock for Q4 2014, up 51% quarter-over-quarter.
  • 6 funds opened new Bio-Path Holdings Inc positions in Q4 2014 and 5 closed out, a net change of +1 holder.
  • The largest Bio-Path Holdings Inc buyer in Q4 2014 was Creative Planning, an estimated $3.96M added.
  • The largest Bio-Path Holdings Inc seller in Q4 2014 was Bluefin Capital Management, an estimated $233K sold.

Based on aggregated 13F filings for Q4 2014.